Why Ibogaine Deserves Decriminalisation
Ibogaine is a unique compound that stands apart from the category of classic psychedelics like psilocybin or LSD. It is an oneirogen, a term derived from the Greek word “oneiros,” meaning dream. Unlike classic psychedelics, which primarily alter perception, an oneirogen induces dream-like states that allow deep introspection and emotional processing. This distinction is critical in understanding the potential of Ibogaine as one of the therapeutic tools we use here at Iboga Root Sanctuary (Ibogaine Treatment UK).
Despite its promising applications, Ibogaine remains classified as a Schedule I substance in the United States, and most countries around the world; a designation that undermines its immense potential for healing, while advocates continue to raise awareness about why Ibogaine deserves decriminalisation. This question goes beyond addiction treatment to address the broader therapeutic value of oneirogens and other psychedelics, as well as the historical injustices surrounding their prohibition.

The Opioid Crisis and Ibogaine’s Potential
The opioid epidemic continues to ravage the United States, claiming over 100,000 lives annually due to overdose. Current treatments such as methadone or Suboxone merely manage addiction, often creating new dependencies, whereas ibogaine offers a revolutionary alternative. By interrupting addiction cycles, alleviating withdrawal symptoms, and facilitating profound psychological insight, Ibogaine provides a path to recovery unlike any other.
Why Ibogaine deserves decriminalisation becomes evident when we consider its ability to address both the physiological and psychological roots of addiction. Administered in controlled settings, Ibogaine has shown life-changing results for individuals struggling with substance dependency and mental health issues yet its classification as a Schedule I substance continues to restrict access to this transformative treatment.

Richard Nixon and America’s Great Mistake
To understand why Ibogaine and other psychedelics remain so tightly controlled, we must revisit the era of the Nixon administration. The War on Drugs, launched in the early 1970s, was as much a political manoeuvre as a public health campaign. It targeted countercultural movements and marginalised communities, using the criminalisation of substances like Ibogaine as a tool for suppression.
This historical context sheds light on why Ibogaine deserves decriminalisation today. The policy decisions of that era were not based on scientific evidence but rather on political expediency. Revisiting these outdated classifications is a necessary step toward justice and evidence-based healthcare.

Ibogaine as More Than a Mere Addiction Interrupter
Ibogaine’s therapeutic potential extends far beyond addiction. Research has revealed its ability to stimulate the production of glial cell-derived neurotrophic factor (GDNF), which promotes the regeneration of dopamine-producing neurons. This makes Ibogaine a promising candidate for treating neurodegenerative diseases such as Parkinson’s and multiple sclerosis, which we treat at our Mexico-based clinic, Genesis Parkinson’s Institute.
By addressing both neurological conditions, mental health issues and addiction, Ibogaine demonstrates why its therapeutic potential cannot be ignored. Advocates argue that why Ibogaine deserves decriminalisation should include its capacity to drive innovation in the treatment of chronic neurodegenerative diseases. This dual role underscores its significance not just as an addiction intervention but as a groundbreaking tool for holistic healthcare.
Joe Rogan Uses His Platform for Decriminalisation of Ibogaine
One of the most prominent advocates for psychedelics and oneirogens is Joe Rogan, whose podcast has brought these issues into the mainstream. Rogan recently discussed the therapeutic value of Ibogaine and other psychedelics such as ayahuasca, psilocybin and 5-MeO-DMT, criticising their outdated scheduling and highlighting the harm caused by prohibition.
By asking why Ibogaine deserves decriminalisation, Rogan gives a platform to researchers, advocates, and those whose lives have been transformed by these treatments. His influence is shifting public perception, creating a groundswell of support for legislative reform.
The Push for Education and Research Around Ibogaine and Psychedelics
Despite its promising applications, Ibogaine, like other psychedelics, remains burdened by stigma. Its psychoactive properties are often misunderstood, leading to unfounded fears about its safety. Critics overlook the rigorous protocols in place at treatment centres, where Ibogaine is administered under medical supervision.
The answer to why Ibogaine deserves decriminalisation lies in education. By disseminating clear, evidence-based information about Ibogaine’s mechanisms and safety profile, advocates can challenge misconceptions and build public support for reform.
Global Models for Reform
While the United States lags in recognising Ibogaine’s therapeutic value despite some interest on behalf of the current Republican administration, other countries are taking the lead. Clinics such as Genesis Parkinson’s Institute in Mexico, and others in Canada, and Tabula Rasa Retreat in Portugal have successfully integrated Ibogaine into healthcare frameworks, demonstrating its safety and efficacy. These international examples provide a compelling argument for why Ibogaine deserves decriminalisation.
By following these models, the US could position itself as a leader in psychedelic research and treatment, unlocking the full potential of substances like Ibogaine to address issues such as addiction, PTSD, depression and neurological disorders like Parkinson’s disease.
A Call to Action
The decriminalisation of Ibogaine is not just a matter of public health but a moral imperative. As the opioid crisis continues unabated and neurodegenerative diseases claim more lives, the case for reform grows stronger.
The reasons for which Ibogaine deserves decriminalisation is a question that demands action from policymakers, healthcare professionals, and advocates alike. By revisiting outdated legislation and embracing the evidence, we can unlock the transformative potential of Ibogaine and give hope to millions.